Advertisement

Topics

Seattle Genetics halts late-stage study of leukemia drug

13:35 EDT 19 Jun 2017 | Reuters

(Reuters) - Seattle Genetics Inc said it would halt a late-stage study of its drug to treat a type of leukemia in older patients following a "higher rate" of deaths in patients on the drug compared with those on a placebo.

Original Article: Seattle Genetics halts late-stage study of leukemia drug

NEXT ARTICLE

More From BioPortfolio on "Seattle Genetics halts late-stage study of leukemia drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...